Icon

STIOLTO RESPIMAT (nda206756)- (EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH)

OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE BOEHRINGER INGELHEIM
EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH
Yes No
2030-Oct-16 2019-Jul-31
None None
None No
STIOLTO RESPIMAT is a combination of tiotropium, an anticholinergic and olodaterol, a long-acting beta2-adrenergic agonist (LABA) indicated for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.